GPR68 is substantially expressed (>5 transcripts per million [TPM]) in several tumor types, notably in head and neck squamous carcinoma (HNSC), cervical squamous cell carcinoma (CESC), pancreatic and lung cancers among others. This evidence concerns the gene GPR68 and cervical squamous cell carcinoma.